C0242184||Hypobaric Hypoxia
C0162770||Right Ventricular Hypertrophy
C0162638||Apoptosis
C0034721||Rats
C0010467||Nanocurcumin
C0392673||Adaptation
C0242184||hypobaric hypoxia
C0162770||right ventricular hypertrophy
C0162638||apoptosis
C0034721||rats
C0010467||nanocurcumin
C0392673||adaptation
C0225808||right heart
C0162770||right ventricular hypertrophy
C0162770||right ventricular hypertrophy
C0231187||decompensation
C0016663||pathological damage
C0010467||Curcumin
C0003402||antioxidant
C1254351||antihypertrophic agent
C0010467||curcumin
C0010467||nanocurcumin
C0010467||curcumin
C0010467||nanocurcumin
C0018787||cardiac
C0242184||hypobaric hypoxia
C0242184||hypobaric hypoxia
C0162770||right ventricular hypertrophy
C0010467||curcumin
C0034715||Sprague-Dawley rats
C0242184||hypobaric hypoxia
C0162770||right ventricular hypertrophy
C0596790||interstitial
C0009325||collagen
C0918012||Fulton's index
C0225828||cardiomyocyte
C0552389||cross-sectional area
C0949479||upregulating
C0034684||atrial natriuretic peptide
C0010957||Tissue damage
C0162638||apoptotic cell death
C0010749||cytochrome-c
C0291573||caspase-3
C0014429||activation
C1515232||TUNEL assay
C0018338||cyclic guanosine monophosphate
C0018338||cyclic guanosine monophosphate
C3494378||cGK-1
C0248868||calmodulin-dependent protein kinase II
C0248868||CaMkinase II
C0178719||intracellular
C0428302||calcium levels
C0016693||free radical
C0010957||damage
C0023775||lipid peroxidation
C0225808||right heart
C0030664||pathology
C0010467||Nanocurcumin
C1735596||supplementation
C0242184||hypobaric hypoxia
C0162770||right ventricular hypertrophy
C0162638||apoptosis
C0018787||cardiac
C0018338||cyclic guanosine monophosphate
C3494378||cGK-1
C0037080||signaling
C0248868||CaMkinase II
C0178719||intracellular
C0428302||calcium levels
C0030012||redox status
C0010467||curcumin
C0010467||Nanocurcumin
C0243095||antiapoptotic effects
C0242184||hypoxic
C0018787||cardiac